UROLOGY, cilt.78, sa.4, 2011 (SCI-Expanded, Scopus)
OBJECTIVE To evaluate the mechanism of action of imatinib mesylate (Gleevec), a protein tyrosine kinase inhibitor on the human prostate with benign prostatic hyperplasia.